English  |  正體中文  |  简体中文  |  總筆數 :2856708  
造訪人次 :  53586505    線上人數 :  826
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu c j"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1076-1100 / 2308 (共93頁)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-12-02T02:34:34Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:33Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:31Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:30Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏 2020-12-02T02:34:30Z Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: The incidence, patient characteristics, and clinical significance Su W.-J.; Shu C.-C.; Lai H.-C.; Lee C.-H.; Yu M.-C.; PAN-CHYR YANG; Yu C.-J.; Lee L.-N.; Wang J.-Y.; PAN-CHYR YANG; Lee L.-N.; Hsueh P.-R.; Yu C.-J.; Jerng J.-S.; Wang J.-Y.; Lee C.-H.; Shu C.-C.
臺大學術典藏 2020-12-02T02:34:30Z Long-term remission of hepatic hydrothorax after OK-432 pleurodesis Lin P.-Y.; Kuo P.-H.; Yu C.-J.; Pan-Chyr Yang; Lin P.-Y.; Kuo P.-H.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:29Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:28Z PHOX2B mutation-confirmed congenital central hypoventilation syndrome in a chinese family Lee P.; Su Y.-N.; Yu C.-J.; Pan-Chyr Yang; Wu H.-D.; Lee P.; Su Y.-N.; Yu C.-J.; PAN-CHYR YANG; Wu H.-D.
臺大學術典藏 2020-12-02T02:34:28Z Management of severe community-acquired septic meningitis in adults: From emergency department to intensive care unit Hsu C.-L.; Chang C.-H.; Wong K.-N.; Chen K.-Y.; Yu C.-J.; Pan-Chyr Yang; Hsu C.-L.; Chang C.-H.; Wong K.-N.; Chen K.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:27Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏 2020-12-02T02:34:27Z The evolution of drug-resistant microorganisms in patients with prolonged mechanical ventilation Chien J.-Y.; Hsueh P.-R.; Yu C.-J.; Pan-Chyr Yang; Chien J.-Y.; Hsueh P.-R.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:26Z Lower gastrointestinal tract tuberculosis: An important but neglected disease Hsueh P.-R.; Lee L.-N.; Hsiao C.-H.; Yu C.-J.; PAN-CHYR YANG; Lin P.-Y.; Wang J.-Y.; Hsueh P.-R.; Lee L.-N.; Hsiao C.-H.; Yu C.-J.; Pan-Chyr Yang; Lin P.-Y.; Wang J.-Y.
臺大學術典藏 2020-12-02T02:34:25Z Mycobacterium tuberculosis and polymorphonuclear pleural effusion: Incidence and clinical pointers Lin M.-T.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Pan-Chyr Yang; Lin M.-T.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:25Z Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; Pan-Chyr Yang; Luh K.-T.; Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; PAN-CHYR YANG; Luh K.-T.
臺大學術典藏 2020-12-02T02:34:25Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Pan-Chyr Yang; Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:24Z Genetic Polymorphisms of Cytochrome P450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease Cheng S.-L.; Yu C.-J.; Pan-Chyr Yang; Cheng S.-L.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:24Z Factors influencing visibility and diagnostic yield of transbronchial biopsy using endobronchial ultrasound in peripheral pulmonary lesions Huang C.-T.; Ho C.-C.; Tsai Y.-J.; Yu C.-J.; Pan-Chyr Yang; Huang C.-T.; Ho C.-C.; Tsai Y.-J.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:23Z Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis Wang J.-Y.; Lee L.-N.; Yu C.-J.; Chien Y.-J.; Pan-Chyr Yang; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Chien Y.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:22Z Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients Huang C.-T.; Tsai Y.-J.; Shu C.-C.; Lei Y.-C.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Pan-Chyr Yang; The Tami Group; Huang C.-T.; Tsai Y.-J.; Shu C.-C.; Lei Y.-C.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; PAN-CHYR YANG; the TAMI Group
臺大學術典藏 2020-12-02T02:34:21Z Culture result of smear-positive sputum samples after 2 months of antituberculous treatment Lim C.-S.; Lee C.-H.; Chien Y.-J.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Pan-Chyr Yang; Lai H.-C.; Su W.-J.; Shu C.-C.; Yu M.C.; Lim C.-S.; PAN-CHYR YANG et al.
臺大學術典藏 2020-12-02T02:34:21Z Prevention of elastase-induced emphysema in placenta growth factor knock-out mice Cheng S.L.; Wang H.C.; Yu C.J.; Tsao P.N.; Carmeliet P.; Cheng S.J.; Pan-Chyr Yang; Cheng S.L.; Wang H.C.; Yu C.J.; Tsao P.N.; Carmeliet P.; Cheng S.J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:20Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:20Z Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis Wang J.-Y.;Wang J.-T.;Tsai T.-H.;Hsu C.-L.;Yu C.-J.;Hsueh P.-R.;Lee L.-N.;Pan-Chyr Yang; Wang J.-Y.; Wang J.-T.; Tsai T.-H.; Hsu C.-L.; Yu C.-J.; Hsueh P.-R.; Lee L.-N.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:20Z Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease Shu C.-C.;Wu H.-D.;Yu M.-C.;Wang J.-T.;Lee C.-H.;Wang H.-C.;Wang J.-Y.;Lee L.-N.;Yu C.-J.;Pan-Chyr Yang; Shu C.-C.; Wu H.-D.; Yu M.-C.; Wang J.-T.; Lee C.-H.; Wang H.-C.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏 2020-12-02T02:34:19Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors Chen K.-Y.;Chen J.-H.;Shih J.-Y.;Yang C.-H.;Yu C.-J.;Pan-Chyr Yang; Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG

顯示項目 1076-1100 / 2308 (共93頁)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每頁顯示[10|25|50]項目